PF
TEVA icon

Phoenix Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Phoenix Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,202,500
Closed -$18.5K – 449
2025
Q1 		$18.5K Buy
1,202,500
+462,500
+63% +$8.26M ﹤0.01% 368
2024
Q4 		$16.3K Buy
+740,000
New +$13.5M ﹤0.01% 356
2024
Q2 		– Sell
-370,000
Closed -$5.22K – 434
2024
Q1 		$5.22K Buy
+370,000
New +$4.66M ﹤0.01% 411
2022
Q3 		– Sell
-100,000
Closed -$752K – 371
2022
Q2 		$752K Buy
+100,000
New +$871K 0.02% 254

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Phoenix Financial's TEVA Position: Q1 2026 in Review

Phoenix Financial increased its Teva Pharmaceuticals (TEVA) stake by 4.1% in Q1 2026, buying an estimated $54.4M and bringing the position to 42,777,414 shares worth $1.29B. The position accounts for 12.21% of the portfolio, ranked #1.

Phoenix Financial first reported a position in TEVA in Q3 2019 and has held it in 27 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Phoenix Financial held 42,777,414 shares of Teva Pharmaceuticals worth $1.29B as of Q1 2026.
  • Phoenix Financial bought 1,690,283 Teva Pharmaceuticals shares in Q1 2026, an estimated $54.4M.
  • Teva Pharmaceuticals made up 12.21% of Phoenix Financial's portfolio in Q1 2026, its #1 holding.
  • Phoenix Financial first reported a position in Teva Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.